Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events. METHODS: We conducted a randomized trial involving 2287 patients who had objective evidence of myocardial ischemia and significant coronary artery disease at 50 U.S. and Canadian centers. Between 1999 and 2004, we assigned 1149 patients to undergo PCI with optimal medical therapy (PCI group) and 1138 to receive optimal medical therapy alone (medical-therapy group). The primary outcome was death from any cause and nonfatal myocardial infarction during a follow-up period of 2.5 to 7.0 years (median, 4.6). RESULTS: There were 211 primary events in the PCI group and 202 events in the medical-therapy group. The 4.6-year cumulative primary-event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (hazard ratio for the PCI group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P=0.62). There were no significant differences between the PCI group and the medical-therapy group in the composite of death, myocardial infarction, and stroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62); hospitalization for acute coronary syndrome (12.4% vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56); or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33). CONCLUSIONS: As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657 [ClinicalTrials.gov].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended (Fig. 10.5), in part because these high-risk people should already be receiving intensive medical therapy-an approach that provides benefits similar to those of invasive revascularization (208,209).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [208]
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended, in part because these high-risk people should already be receiving intensive medical therapy—an approach that provides benefits similar to those of invasive revascularization (197,198).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [197]
In the citing paper
“OMT with risk modification remains the foundation of management in patients with T2DM and CAD.263,264”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [264]
In the citing paper
“these high-risk patients should already be receiving intensive medical therapy -an approach that provides benefi t similar to invasive revascularization (172,173).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [172]
In the citing paper
“The screening of asymptomatic patients remains controversial, especially as intensive medical therapy indicated in diabetic patients at high risk for CVD has an increasing evidence base for providing equal outcomes to invasive revascularization, including in diabetic patients (222).”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [222]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Self-citationThe SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Research works printed but not linked: 2
- 1994, Lancet, 344, 1383
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
Cited by
Items 301–400 of 1,002
Werner, G. S., Gitt, A. K., Zeymer, U., Juenger, C., Towae, F., Wienbergen, H., & Senges, J. (2009) · Clinical Research in Cardiology · doi:10.1007/s00392-009-0013-5 · Cited by 134
“In the light of recent important trials of PCI versus conservative management showing no benefit for PCI, it should be emphasized that the patients with a CTO within the STAR registry are not comparable to the post MI patients of the OAT study [13], and that these patients would have been probably excluded from the re…”
Sdringola, S. M., Johnson, N. P., Kirkeeide, R. L., Cid, E., & Gould, K. L. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.02.008 · Cited by 129
Shaw, L. J., Hage, F. G., Berman, D. S., Hachamovitch, R., & Iskandrian, A. E. (2012) · Journal of Nuclear Cardiology · doi:10.1007/s12350-012-9593-y · Cited by 131
Self-citationWeintraub, W. S., Boden, W. E., Zhang, Z., Kolm, P., Zhang, Z., Spertus, J. A., Hartigan, P. M., Veledar, E., Jurkovitz, C. T., Bowen, J., et al. (2008) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.798462 · Cited by 131
Self-citationNakano, S., Kohsaka, S., Chikamori, T., Fukushima, K., Kobayashi, Y., Kozuma, K., Manabe, S., Matsuo, H., Nakamura, M., Ohno, T., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-21-1041 · Cited by 146
Comprehensive Cardiovascular Risk Factor Control Improves Survival
Bittner, V., Bertolet, M., Barraza Felix, R., Farkouh, M. E., Goldberg, S., Ramanathan, K. B., Redmon, J. B., Sperling, L., & Rutter, M. K. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.019 · Cited by 127
Is There an Obesity Paradox After Percutaneous Coronary Intervention in the Contemporary Era?
Lancefield, T. F., Clark, D. J., Andrianopoulos, N., Brennan, A., Reid, C. M., Johns, J., Freeman, M., Charter, K., Duffy, S. J., Ajani, A. E., et al. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.03.018 · Cited by 148
Bavry, A. A., & Bhatt, D. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60922-8 · Cited by 127
Schroeder, M., Clarke, K., Neubauer, S., & Tyler, D. J. (2011) · Circulation · doi:10.1161/circulationaha.111.024919 · Cited by 134
Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief
Wijeysundera, H. C., Nallamothu, B. K., Krumholz, H. M., Tu, J. V., & Ko, D. T. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-6-201003160-00007 · Cited by 126
Korosoglou, G., Elhmidi, Y., Steen, H., Schellberg, D., Riedle, N., Ahrens, J., Lehrke, S., Merten, C., Loßnitzer, D., Radeleff, J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.020 · Cited by 126
“Virtual” (Computed) Fractional Flow Reserve
Morris, P., van de Vosse, F. N., Lawford, P. V., Hose, D. R., & Gunn, J. P. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.04.006 · Cited by 126
“Finally, despite the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) trial data (5,6), some clinicians remain skeptical of the value of PCI in the context of stable coronary artery disease (7), which reduces enthusiasm for invasive FFR assessment.”
BackgroundKoskinas, K. C., Chatzizisis, Y. S., Baker, A. B., Edelman, E. R., Stone, P. H., & Feldman, C. L. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328331630b · Cited by 125
Lópes, R. D., Alexander, K. P., Stevens, S. R., Reynolds, H. R., Stone, G. W., Piña, I. L., Rockhold, F. W., Elghamaz, A., Lopez-Sendon, J. L., Farsky, P. S., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.050304 · Cited by 140
Self-citationBorgia, F., Viceconte, N., Ali, O., Stuart-Buttle, C., Saraswathyamma, A., Parisi, R., Mirabella, F., Dimopoulos, K., & Mario, C. D. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.04.023 · Cited by 123
Diagnosis and Management of Stable Angina: A Review
Joshi, P. H., & de Lemos, J. A. (2021) · JAMA · doi:10.1001/jama.2021.1527 · Cited by 144
Patel, R. K., Mark, P. B., Johnston, N., McGeoch, R. J., Lindsay, M. M., Kingsmore, D. B., Dargie, H. J., & Jardine, A. G. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02281.x · Cited by 123
“Moreover, there is little evidence that CV screening is of any benefit to patients particularly in the light of evidence from the general population that suggests coronary intervention does not improve survival of asymptomatic patients (15).”
BackgroundDagenais, G. R., Lu, J., Faxon, D. P., Kent, K., Lago, R. M., Lezama, C., Hueb, W., Weiss, M., Slater, J., Frye, R. L., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.978247 · Cited by 123
Williams, B., Menon, M., Satran, D., Hayward, D., Hodges, J. S., Burke, M. N., Johnson, R. K., Poulose, A. K., Traverse, J. H., & Henry, T. D. (2010) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22431 · Cited by 121
Computed Fractional Flow Reserve (FFTCT) Derived from Coronary CT Angiography
Zarins, C. K., Taylor, C. A., & Min, J. K. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9498-4 · Cited by 121
“Recent randomized trials have shown no survival benefit in patients undergoing angiographically guided coronary revascularization compared to medical treatment alone [26, 27] and have highlighted the need for physiologic testing prior to coronary revascularization.”
BackgroundCoronary Atherosclerosis: Pathophysiologic Basis for Diagnosis and Management
Boudoulas, K. D., Triposkiadis, F. K., Geleris, P., & Boudoulas, H. K. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.04.003 · Cited by 152
Hannan, E. L., Racz, M. J., Gold, J. P., Cozzens, K. S., Stamato, N. J., Powell, T., Hibberd, M., & Walford, G. D. (2010) · Circulation · doi:10.1161/circulationaha.109.887539 · Cited by 119
Stress Myocardial Perfusion Imaging for Assessing Prognosis: An Update
Bourque, J. M., & Beller, G. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.10.003 · Cited by 120
Twenty-Year Evolution of Percutaneous Coronary Intervention and Its Impact on Clinical Outcomes
Venkitachalam, L., Kip, K. E., Selzer, F., Wilensky, R. L., Slater, J. N., Mulukutla, S. R., Marroquin, O. C., Block, P. C., Williams, D. O., & Kelsey, S. F. (2008) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.108.825323 · Cited by 119
Chimowitz, M. I., Lynn, M., Turan, T. N., Fiorella, D., Lane, B. F., Janis, S., & Derdeyn, C. P. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2011.05.001 · Cited by 135
Management of Left Main Coronary Artery Disease
Ramadan, R., Boden, W. E., & Kinlay, S. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008151 · Cited by 129
Self-citationCheng, A. S. H., Selvanayagam, J. B., Jerosch‐Herold, M., van Gaal, W. J., Karamitsos, T. D., Neubauer, S., & BANNING, A. P. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2007.11.003 · Cited by 116
Appropriateness of Percutaneous Coronary Intervention
Gersh, B. J. (2012) · Yearbook of Cardiology · doi:10.1016/j.ycar.2012.01.048 · Cited by 115
2024 Clinical practice guidelines for Stable coronary artery disease
Барбараш, О. Л., Karpov, Y. A., Panov, A. V., Akchurin, R. S., Alekyan, B. G., Alekhin, M. N., Aronov, D. M., HARUTYUNYAN, G., Belenkov, Y. N., Boytsov, S. A., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6110 · Cited by 182
Sedlis, S. P., Jurkovitz, C. T., Hartigan, P. M., Goldfarb, D. S., Lorin, J. D., Dada, M. R., Maron, D. J., Spertus, J. A., Mancini, G. B. J., Teo, K. K., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.07.043 · Cited by 115
Self-citationKim, H., Koo, B., Nam, C., Doh, J., Kim, J.-H., Yang, H., Park, K. W., Lee, H., Kang, H., Cho, Y., et al. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.06.017 · Cited by 114
“It is well known that stent placement should be perormed only for functionally significant stenosis (15,16).”
BackgroundStress Myocardial CT Perfusion
Techasith, T., & Cury, R. C. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.04.017 · Cited by 114
Stamatakis, E., Weiler, R., & Ioannidis, J. P. A. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12074 · Cited by 113
The Truth and Consequences of the COURAGE Trial
Kereiakes, D. J., Teirstein, P. S., Sarembock, I. J., Holmes, D. R., Krucoff, M. W., O’Neill, W. W., Waksman, R., Williams, D. O., Popma, J. J., Buchbinder, M., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.063 · Cited by 113
Gaemperli, O., Bengel, F. M., & Kaufmann, P. A. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr057 · Cited by 121
“The two largest randomized trials, the COURAGE and BARI-2D trials, both including patients with angiographically documented CAD, have failed to demonstrate a prognostic benefit of revascularization strategies compared with contemporary medical therapies.(8,9) A retrospective observation in .”
Backgroundthe DYNAMIT investigators, Lièvre, M. M., Moulin, P., Thivolet, C., Rodier, M., Rigalleau, V., Penfornis, A., Pradignac, A., & Ovize, M. (2011) · Trials · doi:10.1186/1745-6215-12-23 · Cited by 114
Al-Lamee, R. K., Howard, J. P., Shun-Shin, M. J., Thompson, D. M., Dehbi, H., Sen, S., Nijjer, S. S., Petraco, R., Davies, J. R., Keeble, T., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.033801 · Cited by 126
Ge, Y., Pandya, A., Steel, K. E., Bingham, S. E., Jerosch‐Herold, M., Chen, Y.-Y., Mikolich, J. R., Arai, A. E., Bandettini, W. P., Patel, A. R., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.02.029 · Cited by 111
“The value of the latter, particularly in stable coronary disease, is controversial (33) and is currently under investigation in an ongoing large randomized trial (34).”
BackgroundMin, J. K., Gilmore, A. S., Budoff, M. J., Berman, D. S., & O’Day, K. (2010) · Radiology · doi:10.1148/radiol.09090349 · Cited by 110
Self-citationThe Impact of Coronary Physiology on Contemporary Clinical Decision Making
Kogame, N., Ono, M., Kawashima, H., Tomaniak, M., Hara, H., Leipsic, J. A., Andreini, D., Collet, C. A., Patel, M. R., Tu, S., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.04.040 · Cited by 128
Leuschner, F., & Nahrendorf, M. (2011) · Circulation Research · doi:10.1161/circresaha.110.232678 · Cited by 110
Bittencourt, M. S., Hulten, E. A., Polonsky, T. S., Hoffman, U., Nasir, K., Abbara, S., Carli, M. F. D., & Blankstein, R. (2016) · Circulation · doi:10.1161/circulationaha.116.023396 · Cited by 125
Prognostic Impact of Chronic Total Occlusions
Råmunddal, T., Hoebers, L. P. C., Henriques, J. P. S., Dworeck, C., Angerås, O., Odenstedt, J., Ioanes, D., Olivecrona, G. K., Harnek, J., Jensen, U. J., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.04.031 · Cited by 118
Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm
Ferraro, R., Latina, J. M., Alfaddagh, A., Michos, E. D., Blaha, M. J., Jones, S. R., Sharma, G. V., Trost, J. C., Boden, W. E., Weintraub, W. S., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.078 · Cited by 131
Self-citationMcCullough, P. A. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03871106 · Cited by 144
Gersh, B. J. (2009) · Yearbook of Medicine · doi:10.1016/s0084-3873(09)79441-6 · Cited by 108
Greif, M., von Ziegler, F., Bamberg, F., Tittus, J., Schwarz, F., D’Anastasi, M., Marcus, R. P., Schenzle, J. C., Becker, C. R., Nikolaou, K., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-303794 · Cited by 107
Patel, K., Spertus, J. A., Chan, P. S., Sperry, B. W., Thompson, R. C., Badarin, F. J. A., Kennedy, K. F., Case, J. A., Courter, S. A., Saeed, I. M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.055 · Cited by 109
“Two large randomized clinical trials (1,2) have shown that revascularization, compared with aggressive medical therapy, does not reduce major adverse cardiac events or improve survival in patients with stable CAD.”
Self-citationHandberg, E. M., Merz, C. N. B., Cooper‐DeHoff, R. M., Wei, J., Conlon, M., Lo, M. C., Boden, W. E., Frayne, S. M., Villines, T. C., Spertus, J. A., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.03.011 · Cited by 119
Self-citation2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary
Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.006 · Cited by 118
Self-citationOutcomes of Percutaneous Coronary Intervention in Intermediate Coronary Artery Disease
Nam, C., Yoon, H., Cho, Y., Park, H., Kim, H., Hur, S., Kim, Y.-N., Chung, I., Koo, B., Tahk, S.-J., et al. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.04.016 · Cited by 107
Paclitaxel-Eluting Coronary Stents in Patients With Diabetes Mellitus
Kirtane, A. J., Ellis, S. G., Dawkins, K. D., Colombo, A., Grube, E., Popma, J. J., Fahy, M. P., Leon, M. B., Moses, J. W., Mehran, R., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.035 · Cited by 107
Aspelund, T., Gudnason, V., Magnusdottir, B. T., Andersen, K., Sigurdsson, G., Thorsson, B., Steingrimsdottir, L., Critchley, J., Bennett, K., O'Flaherty, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013957 · Cited by 106
“The contribution from revascularizations was modest, reflecting a relatively small number of eligible patients and limited mortality benefits in stable angina[25].”
BackgroundMedical reversal: why we must raise the bar before adopting new technologies.
Prasad, V. K., & Cifu, A. S. (2011) · PubMed Central · Cited by 125
Thalji, N. M., Suri, R. M., Daly, R. C., Greason, K. L., Dearani, J. A., Stulak, J. M., Joyce, L. D., Burkhart, H. M., Pochettino, A. A., Li, Z., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.08.073 · Cited by 119
“Mechanical ventilation, h 12 (7-17) 13 (8-18) 9 (6-16) <.”
Nishigaki, K., Yamazaki, T., Kitabatake, A., Yamaguchi, T., Kanmatsuse, K., Kodama, I., Takekoshi, N., Tomoike, H., Hori, M., Matsuzaki, M., et al. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.08.002 · Cited by 106
Nurmohamed, N. S., van Rosendael, A. R., Danad, I., Ngo‐Metzger, Q., Taub, P. R., Ray, K. K., Figtree, G. A., Bonaca, M. P., Hsia, J. A., Rodríguez, F., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae190 · Cited by 133
Self-citationThe Clinical Impact of Routine Angiographic Follow-Up in Randomized Trials of Drug-Eluting Stents
Uchida, T., Popma, J. J., Stone, G. W., Ellis, S. G., Turco, M. A., Ormiston, J. A., Muramatsu, T., Nakamura, M., Nanto, S., Yokoi, H., et al. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.01.010 · Cited by 104
Lentine, K. L., Hurst, F. P., Jindal, R. M., Villines, T. C., Kunz, J. S., Yuan, C. M., Hauptman, P. J., & Abbott, K. C. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.06.032 · Cited by 103
Bourque, J. M., & Beller, G. (2015) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2015.09.006 · Cited by 122
“Moreover, there is increasing evidence in the literature suggesting that revascularization may only be beneficial in patients with high levels of ischemia.(92,99) At the same time, advances in imaging technology have improved diagnostic accuracy while decreasing test duration and radiation exposure, thereby shifting t…”
2013 ESC GUIDELINES ON THE MANAGEMENT OF STABLE CORONARY ARTERY DISEASE
Montalescot, G., Sechtem, U. P., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., Mario, C. D., et al. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-7-7-79 · Cited by 109
Functional assessment of coronary stenoses: can we live without it?
Pijls, N. H. J., Tanaka, N., & Fearon, W. F. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs436 · Cited by 101
“In the COURAGE study, optimum medical treatment alone was compared with PCI in addition to medical treatment in patients with multivessel disease and moderately severe coronary disease.(3,4) In most patients bare metal stents were used.”
BackgroundMethodResultInfluentialLi, L., Cao, J., Li, S., Cui, T., Ni, J., Zhang, H., Zhu, Y., Mao, J., Gao, X., Midgley, A. C., et al. (2023) · Advanced Science · doi:10.1002/advs.202202964 · Cited by 156
Sheiban, I. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.31 · Cited by 101
“However, the prognostic benefi ts in stable patients have been recently debated (Hochman et al 2006), and even symptomatic relief may not be persistent in certain groups of patients (Boden et al 2007).”
Chamberlain, J. J., Johnson, E. L., Leal, S., Rhinehart, A. S., Shubrook, J. H., & Peterson, L. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0222 · Cited by 114
Hu, L.-H., Betancur, J., Sharir, T., Einstein, A. J., Bokhari, S., Fish, M. B., Ruddy, T. D., Kaufmann, P. A., Sinusas, A. J., Miller, E. J., et al. (2019) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jez177 · Cited by 106
Self-citationJCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease
Nakamura, M., Yaku, H., Ako, J., Arai, H., Asai, T., Chikamori, T., Daida, H., Doi, K., Fukui, T., Ito, T., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-20-1282 · Cited by 118
Dual-energy CT of the heart—Principles and protocols
Schwarz, F., Ruzsics, B., Schoepf, U. J., Bastarrika, G., Chiaramida, S. A., Abro, J. A., Brothers, R. L., Vogt, S. K., Schmidt, B. T., Costello, P., et al. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.09.010 · Cited by 100
Fearon, W. F., Shilane, D. A., Pijls, N. H. J., Boothroyd, D. B., Tonino, P. A. L., Barbato, E., Jüni, P., Bruyne, B. D., & Hlatky, M. A. (2013) · Circulation · doi:10.1161/circulationaha.113.003059 · Cited by 99
Stone, G. W., Hochman, J. S., Williams, D. O., Boden, W. E., Ferguson, T. B., Harrington, R. A., & Maron, D. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.056 · Cited by 107
Self-citationChen, M. Y., Rochitte, C. E., Arbab‐Zadeh, A., Dewey, M., George, R. T., Miller, J. M., Niinuma, H., Yoshioka, K., Kitagawa, K., Sakuma, H., et al. (2017) · Radiology · doi:10.1148/radiol.2017161565 · Cited by 99
“The Courage study showed that not all patients with coronary artery stenosis benefit from coronary revascularization (2).”
BackgroundAcharjee, S., Boden, W. E., Hartigan, P. M., Teo, K. K., Maron, D. J., Sedlis, S. P., Kostuk, W. J., Spertus, J. A., Dada, M. R., CHAITMAN, B. R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.051 · Cited by 112
Self-citationTang, W. H. W., Wu, Y., Nicholls, S. J., & Hazen, S. L. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.152827 · Cited by 98
Doshi, D., Ben‐Yehuda, O., Bonafede, M., Josephy, N., Karmpaliotis, D., Parikh, M. A., Moses, J. W., Stone, G. W., Leon, M. B., Schwartz, A. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.060 · Cited by 99
“The omission of ischemic CAD testing may prevent patients from being treated with aggressive guideline-directed medical therapies for CAD, which can both alleviate symptoms and reduce hard cardiovascular events (19).”
BackgroundRahimi, K., BANNING, A. P., Cheng, A. S. H., Pegg, T. J., Karamitsos, T. D., Channon, K. M., Darby, S. C., Taggart, D. P., Neubauer, S., & Selvanayagam, J. B. (2009) · Heart · doi:10.1136/hrt.2009.173302 · Cited by 98
Lee, P. H., Lee, S., Park, H.-S., Kang, S. H., Bae, B. J., Chang, M., Roh, J., Yoon, S., Ahn, J., Park, D., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.11.016 · Cited by 97
“Given the specific clinical and angiographic characteristics of CTOs, the optimalmedical therapy alone for these complex lesions has been advocated, particularly in view of results of a previous large randomized trial demonstrating no clear death or MI benefit from an initial strategy of revascularization in patients…”
JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases
Yamagishi, M., Tamaki, N., Akasaka, T., Ikeda, T., Ueshima, K., Uemura, S., Otsuji, Y., Kihara, Y., Kimura, K., Kimura, T., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-19-1131 · Cited by 107
Williams, S. A., Ostroff, R., Hinterberg, M. A., Coresh, J., Ballantyne, C. M., Matsushita, K., Mueller, C. E., Walter, J., Jonasson, C., Holman, R. R., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj9625 · Cited by 97
“Revascularization procedures were excluded from the composite because of the contemporary changing frequency of nonacute procedures (50, 51) and because of likely geographic variation.”
BackgroundFleisher, L. A., Fleischmann, K. E., Auerbach, A. D., Barnason, S. A., Beckman, J. A., Bozkurt, B., Dávila‐Román, V. G., Gerhard‐Herman, M. D., Holly, T. A., Kane, G. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.945 · Cited by 113
Grace, S. L., Chessex, C., Arthur, H. M., Chan, S., Cyr, C., Dafoe, W. A., Juneau, M., OH, P. I., & Suskin, N. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.007 · Cited by 113
Herzog, B. A., Wyss, C. A., Husmann, L., Gaemperli, O., Valenta, I., Treyer, V., Landmesser, U., & Kaufmann, P. A. (2009) · Heart · doi:10.1136/hrt.2008.162420 · Cited by 97
“achieved by using prospective ECG-triggering of CTCA may have a profound impact on the perception of the optimal patient population benefiting most from non-invasive CTCA. It is an accepted rule that for reasons of radiation protection the total dose applied to a given population should be kept as low as reasonably ac…”
Bangalore, S., Pursnani, S. K., Kumar, S., & Bagos, P. G. (2013) · Circulation · doi:10.1161/circulationaha.112.131961 · Cited by 103
Illuminati, G., Ricco, J., Greco, C., Mangieri, E., Calio’, F. G., Ceccanei, G., Pacilè, M. A., Schiariti, M. S., Tanzilli, G., Barillà, F., et al. (2009) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2009.11.015 · Cited by 96
Hussain, S. T., Paul, M., Plein, S., McCann, G. P., Shah, A. M., Marber, M. S., Chiribiri, A., Morton, G., Redwood, S. R., MacCarthy, P. A., et al. (2012) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-14-65 · Cited by 96
“The COURAGE [1] trial has shown no benefit of routine revascularisation both in terms of prognosis and long term symptom relief in patients with stable angina.”
MethodCheng, V., Gutstein, A., Wolak, A., Suzuki, Y., Dey, D., Gransar, H., Thomson, L., Hayes, S. W., Friedman, J. D., & Berman, D. S. (2008) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.05.006 · Cited by 96
Self-citationDyslipidemia in South Asian patients
Enas, E. A., Chacko, V., Pazhoor, S. G., Chennikkara, H., & Devarapalli, H. P. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0047-y · Cited by 107
Coronary Anatomy to Predict Physiology: Fundamental Limits
Johnson, N. P., Kirkeeide, R. L., & Gould, K. L. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.000373 · Cited by 107
Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief
Gersh, B. J. (2011) · Yearbook of Cardiology · doi:10.1016/j.ycar.2011.01.112 · Cited by 94
Ranolazine for chronic stable angina
Nash, D. T., & Nash, S. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61554-8 · Cited by 92
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.008 · Cited by 111
Ko, D. T., Guo, H., Wijeysundera, H. C., Natarajan, M. K., Nagpal, D., Feindel, C. M., Kingsbury, K., Cohen, E. A., & Tu, J. V. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.056 · Cited by 94
“One possible reason for the relatively high inappropriate rates is that our study cohort was assembled in 2006 to 2007, around the time the COURAGE study was published and before the publication of the appropriateness use criteria (6,21).”
ResultZhang, D., Lv, S., Song, X., Yuan, F., Xu, F., Zhang, M., Yan, S., & Cao, X. (2015) · Heart · doi:10.1136/heartjnl-2014-306578 · Cited by 91
Park, S., Ahn, J., Park, G., Cho, Y., Lee, J., Kim, W., Han, S., Kang, S.-J., Park, D., Lee, S., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht404 · Cited by 91
“Large randomized clinical trials comparing the revascularization and the optimal medical treatment such as the Clinical Outcomes Utilizing Revascularization and Aggressive drug Evaluation (COURAGE) failed to demonstrate the benefit of stent implantation for the prevention of death, non-fatal MI, unplanned revasculariz…”
MethodPercutaneous coronary intervention in the elderly
Wang, T. Y., Gutiérrez, A., & Peterson, E. D. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.184 · Cited by 101
Analysis of arterial intimal hyperplasia: review and hypothesis
Subbotin, V. M. (2007) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-4-41 · Cited by 95
Regulation of ABCA1 functions by signaling pathways
Liu, Y., & Tang, C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.08.015 · Cited by 90
Ladapo, J. A., Jaffer, F. A., Hoffmann, U., Thomson, C. C., Bamberg, F., Dec, G. W., Cutler, D., Weinstein, M. C., & Gazelle, G. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.012 · Cited by 89
Invasive FFR and Noninvasive CFR in the Evaluation of Ischemia
Johnson, N. P., Gould, K. L., Carli, M. F. D., & Taqueti, V. R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.584 · Cited by 100
Husmann, L., Herzog, B. A., Gaemperli, O., Tatsugami, F., Burkhard, N., Valenta, I., Veit‐Haibach, P., Wyss, C. A., Landmesser, U., & Kaufmann, P. A. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn536 · Cited by 90
Lichtman, J. H., Wang, Y., Jones, S. B., Leifheit-Limson, E. C., Shaw, L. J., Vaccarino, V., Rumsfeld, J. S., Krumholz, H. M., & Curtis, J. P. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.11.001 · Cited by 89
Self-citation
Metadata
- Authors
- Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G. B. J., & Weintraub, W. S.
- Affiliations
- VA Western New York Healthcare System (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-12
- Volume
- 356
- Issue
- 15
- Pages
- 1503-1516
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2160414137
- Cited by
- 4,699
- References
- 49
- Citations by year
- 2026: 111 · 2025: 142 · 2024: 150 · 2023: 166 · 2022: 197 · 2021: 255 · 2020: 282 · 2019: 202 · 2018: 227 · 2017: 211 · 2016: 276 · 2015: 263 · 2014: 295 · 2013: 309 · 2012: 322
- FWCI
- 315.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- optimal medical therapy, percutaneous coronary intervention, stable coronary artery disease, myocardial ischemia, cardiovascular events, myocardial infarction, mortality, lifestyle intervention, coronary artery disease
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angina Pectoris, Angiotensin-Converting Enzyme Inhibitors, Anticholesteremic Agents, Antihypertensive Agents, Combined Modality Therapy, Coronary Disease, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Risk Factors, Angioplasty, Balloon, Coronary, Proportional Hazards Models, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.